NCT02472184

Brief Summary

This study will look at the optimal order in which to perform concurrent office hysteroscopy and endometrial biopsy in female patients who present for evaluation of abnormal uterine bleeding at a fibroid and endometriosis treatment center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 15, 2015

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

September 26, 2018

Status Verified

December 1, 2016

Enrollment Period

1.4 years

First QC Date

June 8, 2015

Last Update Submit

September 25, 2018

Conditions

Keywords

Office hysteroscopyEndometrial biopsyAbnormal uterine bleedingUterine fibroids

Outcome Measures

Primary Outcomes (1)

  • Patient pain scores

    After the procedures are performed, the patient will be asked to describe their pain perception based on Visual analogue scale (VAS) from 0-10

    Immediately following procedures

Secondary Outcomes (3)

  • Adequacy of endometrial sample

    Within 2 weeks following endometrial biopsy

  • Duration of procedure

    Immediately following procedure

  • Visualization of endometrial cavity

    During procedure

Study Arms (2)

Office Hysteroscopy

ACTIVE COMPARATOR

Group of patients in which office hysteroscopy will be performed prior to endometrial biopsy

Procedure: Office hysteroscopyProcedure: Endometrial biopsy

Endometrial biopsy

ACTIVE COMPARATOR

Group of patients in which endometrial biopsy will be performed prior to office hysteroscopy

Procedure: Office hysteroscopyProcedure: Endometrial biopsy

Interventions

Office hysteroscopy is a procedure performed in the office in which a flexible hysteroscope is inserted into the uterine cavity. The patient is positioned in a dorsal lithotomy position and teh cervix is visualized with a speculum. Normal saline is used to distend the cavity, and the hysteroscope is used to visualize any abnormalities within the cavity.

Endometrial biopsyOffice Hysteroscopy

An endometrial biopsy is a procedure in which a pipelle instrument is inserted into the uterine cavity and suction from the pipelle is used to obtain endometrial tissue. This is performed with the patient in the dorsal lithotomy position and a speculum is used to visualize the cervix.

Endometrial biopsyOffice Hysteroscopy

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All consecutive female patients ages 18-70 presenting to the Center for Fibroid and Endometriosis Research and Treatment for medically indicated office hysteroscopy and endometrial biopsy for evaluation of abnormal uterine bleeding and or uterine fibroids with ability to provide written informed consent.

You may not qualify if:

  • Patients unable to provide informed consent
  • Patients presenting to the Center for Fibroid and Endometriosis Research and Treatment for medically indicated office hysteroscopy and endometrial biopsy for evaluation of abnormal uterine bleeding and or uterine fibroids are not deemed clinically indicated based on the assessment of their clinical provider.
  • Patients in which office hysteroscopy or endometrial biopsy is unsuccessful due to patient discomfort, known cervical stenosis, or poor visualization of the cervix

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Florida College of Medicien Department of Obstetrics and Gynecology

Tampa, Florida, 33606, United States

Location

Related Publications (6)

  • Committee on Practice Bulletins-Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul;120(1):197-206. doi: 10.1097/AOG.0b013e318262e320. No abstract available.

    PMID: 22914421BACKGROUND
  • Technology assessment No. 7: Hysteroscopy. Obstet Gynecol. 2011 Jun;117(6):1486-1491. doi: 10.1097/AOG.0b013e3182238c7d.

    PMID: 21606772BACKGROUND
  • Kelekci S, Kaya E, Alan M, Alan Y, Bilge U, Mollamahmutoglu L. Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding. Fertil Steril. 2005 Sep;84(3):682-6. doi: 10.1016/j.fertnstert.2005.03.036.

    PMID: 16169403BACKGROUND
  • Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002 Oct 2;288(13):1610-21. doi: 10.1001/jama.288.13.1610.

    PMID: 12350192BACKGROUND
  • Ghaly S, de Abreu Lourenco R, Abbott JA. Audit of endometrial biopsy at outpatient hysteroscopy. Aust N Z J Obstet Gynaecol. 2008 Apr;48(2):202-6. doi: 10.1111/j.1479-828X.2008.00834.x.

    PMID: 18366496BACKGROUND
  • Sarkar P, Mikhail E, Schickler R, Plosker S, Imudia AN. Optimal Order of Successive Office Hysteroscopy and Endometrial Biopsy for the Evaluation of Abnormal Uterine Bleeding: A Randomized Controlled Trial. Obstet Gynecol. 2017 Sep;130(3):565-572. doi: 10.1097/AOG.0000000000002202.

MeSH Terms

Conditions

LeiomyomaUterine HemorrhageMetrorrhagia

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Anthony Imudia, MD

    University of South Florida College of Medicine Department of Infertility and Reproductive Endocrinology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2015

First Posted

June 15, 2015

Study Start

October 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

September 26, 2018

Record last verified: 2016-12

Locations